Channel Therapeutics Corp...

NYSE: PTHS · Real-Time Price · USD
20.51
-0.75 (-3.53%)
At close: Aug 19, 2025, 3:50 PM
21.31
3.90%
After-hours: Aug 19, 2025, 05:16 PM EDT

Channel Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-7.57M -6.86M -2.32M -839K
Interest Income
n/a n/a n/a n/a
Pretax Income
-7.96M -7.38M -2.46M -595.39K
Net Income
-7.96M -7.38M -2.46M -595.39K
Selling & General & Admin
6.39M 4.28M 1.93M 629.95K
Research & Development
1.18M 2.58M 391.73K 209.05K
Other Expenses
n/a n/a n/a n/a
Operating Expenses
7.57M 6.86M 2.32M 839K
Interest Expense
786.39K 518.51K 140.43K 253.00
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
7.57M 6.86M 2.32M 839K
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
n/a 576.75K 928.69K 576.75K
Shares Outstanding (Diluted)
n/a 576.75K 928.69K 576.75K
EPS (Basic)
n/a -12.8 -2.6 -1
EPS (Diluted)
n/a -12.8 -2.6 -1
EBITDA
-7.17M -6.86M -2.32M -595.13K
EBIT
-7.17M -6.86M -2.32M -595.13K
Depreciation & Amortization
n/a n/a n/a n/a